Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Further delay to India’s biotechnology authority

The introduction of the Biotechnology Regulatory Authority of India (BRAI) Bill into Parliament has been delayed, national media report. The Bill was to be tabled in the Lok Sabha (lower house) of Parliament on the last day of the latest monsoon session, which ended on September 7th. The Science and Technology Minister, Vayalar Ravi, decided to withdraw it at the last minute after facing opposition from some MPs. The founding of the BRAI was proposed by an Agriculture Ministry task force in 2004 ( Agrow No 451, p 20) and the Department of Biotechnology came up with a draft plan in 2008 ( Agrow No 545, p 21). Apart from the slow progress, the proposed BRAI has also been mired in a lot of recent controversy. A report from an Indian parliamentary standing committee, made public last month, recommended a rethink on the scope of the BRAI and suggested the setting up of an “all-encompassing” Biosafety Authority ( Agrow No 646, p 33).

Topics

What to read next

UsernamePublicRestriction

Register

AG012267

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel